Matthew Brams

Matthew Brams, MD is Chief Medical Officer and a Co-Founder of Cingulate Therapeutics. Dr. Brams is Medical Director and Principal of Bayou City Research, Inc. There, he has been instrumental in gaining FDA approval of over 15 Central Nervous System drugs currently in the marketplace. Dr. Brams is also a Clinical Associate Professor at the Menninger Department of Psychiatry of Baylor College of Medicine and has published over 20 peer-reviewed journal articles.

He has been the lead investigator in several pivotal trials involving drugs in ADHD, autism, bipolar disorder, and schizophrenia therapeutic areas. He has extensive experience in drug development and execution of Phase I-IV trials and has been involved in over 125 clinical trials in both adult and pediatric populations in all areas of psychiatry. In addition, he has over 25 years of clinical experience managing patients in the field of Adult and Child Psychiatry with particular expertise in ADHD and Autistic Spectrum Disorders (ASD).

He earned his MD from the University of Texas Health Science Center in Houston and completed his residencies at Baylor College of Medicine. He is Board Certified in Adult and Child Psychiatry and is a Senior Board Examiner for the American Board of Psychiatry and Neurology.